Swinburne university of technology, Public university in Melbourne, Australia

The research is looking to develop effective immunotherapy via a new vaccine to remove 'brain plaque' and tau protein aggregates linked to Alzheimer's disease.Recent success in bigenic mice models supports progression to human trials in years to come, the research added.The study, published in the journal Alzheimer's Research & Therapy paves the way for more work in 2020 ith medical researchers at the Institute for Molecular Medicine and University of California, Irvine (UCI) working with a successful vaccine formulated on adjuvant developed by Flinders University Professor Nikolai Petrovsky in Australia.The researchers tested the universal MultiTEP platform-based vaccines formulated in the adjuvant developed at Australian lab.The possible new therapies were tested in bigenic mice with mix Aß and tau pathologies."Taken together, these findings warrant further development of this dual vaccination strategy based on the MultiTEP technology for ultimate testing in human Alzheimer's disease," said the study lead authors Professor Anahit Ghochikyan and Mathew Blurton-Jones.Professor Petrovsky said the Advax adjuvant method is a pivotal system to help take the combination MultiTEP-based Aß/tau vaccines therapy, as well as separate vaccines targeting these pathological molecules, to clinical trials - perhaps within two years."Our approach is looking to cover all bases and get past previous roadblocks in finding a therapy to slow the accumulation of Aß/tau molecules and delay Alzheimer's disease progression in a the rising number of people around the world," Petrovsky added.Several promising drug candidates have failed in clinical trials so the search for new preventions or therapies continues.A recent report on human monoclonal antibody, aducanumab, showed that high dose of this antibody reduced clinical decline in patients with early Alzheimer's disease as measured by primary and secondary endpoints.However, it is obvious that it could not be used as a preventive measure in healthy subjects due to the need for frequent (monthly) administration of high concentrations of immunotherapeutic.There is a pressing need to keep searching for new preventive vaccine to delay Alzheimer's disease and slow down progression of this devastating disease.The new combined vaccination approach could potentially be used to induce strong immune responses to both of the hallmark pathologies of Alzheimer's disease in a broad population base of vaccinated subjects with high MHC (major histocompatibility complex) class II gene polymorphisms, the study concluded.( With inputs from IANS )

Swinburne University Of TechnologyFOLLOW

Swinburne university of technology, Latest News

Cricket Australia on Wednesday shared a touching moment between Australian coach Justin Langer and an elderly wheelchair-bound fan at the Sydney Cricket Ground. Cricket Australia said that the fan's name is Bill Dean and he says in the video that he ...

Australia star off-spinner Nathan Lyon has put his weight behind five-day Tests as the recent discussions around four-day matches have now become a talking point in the cricketing world. ...

Right-arm pacer Deepak Chahar believes he has been playing "excess matches" in recent times because of which he has suffered from a stress fracture and that's why he needs to be "selective" in his approach in the near future. ...

Australia head coach Justin Langer on Wednesday threw his weight behind Tim Paine, saying the stumper batsman will be the teams captain for the foreseeable future. ...

From Brian Lara to Virat Kohli, Ben Stokes to Steve Smith, the U19 World Cup has never fallen short of showcasing cricket's brightest young stars. ...

Premier Pakistan batter Babar Azam was in great form during the two-Test series against Australia where he accumulated 210 runs, which included a century and a fifty, at an average of 52.50. ...

Spectacular and glittering fireworks were on full display at the Harbour Bridge in Sydney as Australia rang in the New Year. ...

A preventive treatment for dementia may proceed to clinical trials after successful animal testing, say researchers. ...